Obesity: A peptide YY-deficient, but not peptide YY-resistant, state

Endocrinology

Volumn 147, Issue 1, 2006, Pages 1-2

  Young, Andrew A ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE YY;

BODY MASS; FEEDING; FOOD INTAKE; HUMAN; INTESTINE INNERVATION; L CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; SATIETY; SHORT SURVEY; STOMACH EMPTYING; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

DRUG RESISTANCE; HUMANS; OBESITY; PEPTIDE YY; SATIETY RESPONSE;

EID: 29344456750     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1217     Document Type: Short Survey

References (22)

1. Tatemoto K, Mutt V 1980 Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285:417-418
2. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR 1985 Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077
3. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR 2003 Inhibition of food intake in obese subjects by peptide YY[3-36]. N Engl J Med 349:941-948
4. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR 2002 Gut hormone PYY[3-36] physiologically inhibits food intake. Nature 418:650 -654
5. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR 2004 Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145:2687-2695
6. Pittner RA, Moore CX, Bhavsar SP, Gedulin BR, Smith PA, Jodka CM, Parkes DM, Paterniti JR, Srivastava VP, Young AA 2004 Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 28:963-971
7. Drucker DJ 1998 Glucagon-like peptides. Diabetes 47:159-169
8. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314
9. Meier JJ, Nauck MA 2004 GIP as a potential therapeutic agent? Horm Metab Res 36:859-866
10. le Roux CW, Batterham RL, Aylwin SJB, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR 2006 Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3-8
11. Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-Sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Withcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, HeimanML2004 Physiology: does gut hormone PYY[3-36] decrease food intake in rodents? Nature 430:1-3
12. Adams SH, Won WB, Schonhoff SE, Leiter AB, Paterniti JR JR 2004 Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels. Endocrinology 145:4967-4975
13. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'Rahilly S 2003 Acute effects of PYY[3-36] on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311:915-919
14. Chelikani PK, Haver AC, Reidelberger RD 2005 Intravenous infusion of peptide YY[3-36] potently inhibits food intake in rats. Endocrinology 146:879-888
15. Cox JE, Randich A 2004 Enhancement of feeding suppression by PYY[3-36] in rats with area postrema ablations. Peptides 25:985-989
16. Halatchev IG, Ellacott KL, Fan W, Cone RD 2004 Peptide YY[3-36] inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145:2585-2590
17. Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K, Niiji A, Furuya M, Inomata N, Osuye K, NakazatoM2005 The role of the vagal nerve in peripheral PYY[3-36]-induced feeding reduction in rats. Endocrinology 146:2369-2375
18. Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, Ladenheim EE 2005 Peptide YY[3-36] inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 288:R384-R388
19. Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR 2005 Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 146:5120-5127
20. Allen JM, Fitzpatrick ML, Yeats JC, Darcy K, Adrian TE, Bloom SR 1984 Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30:255-262
21. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR 1987 Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28:166-170
22. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR 1985 Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89:494-499